Scinai Immunotherapeutics Ltd. SCNI US Equity
Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI), an SEC filer in Biological Products, (No Diagnostic Substances), closed at $2.51, -6.3%, on 2026-08-28, with a market cap of $3.5B, a return on equity of -91.9% and a net margin of -633.6%. Institutional ownership, earnings history and filed financials are on the tabs below.
Documents
0 of the 1 10-K originals we hold for SCNI are cached as text on this host and readable here.
Every filing on file is still listed on EVTS · Filings.
▾Risk registerwhich risk-factor headings appeared in which year
Descriptive and within-name: this is what changed in the wording of one firm's own filings.
No 10-K text for SCNI is cached on this host, so there is nothing to compare. The document cache holds the names the filing-narrative ingest covers.
The filer's own 10-K text · 0 filings read
Rows are the filing's own headings, verbatim — nothing is summarized or generated.
A blank cell means the filer did not print that heading that year — not that the risk ended.
Gates: 5+ captions · 50% of Item 1A · match at Jaccard 0.6.
▾Filing languagedocument length, negation and hedging — chart it against price on GRAPH
Descriptive and within-name: this is what changed in the wording of one firm's own filings.
No 10-K text for SCNI is cached on this host. The document cache holds the 10-K originals the filing-narrative ingest fetched — US filers it covers, up to six years each; there is nothing to measure for this name.
The filer's own 10-K text · 0 filings measured
House wordlists, not a licensed dictionary and not tuned against returns.
9 negation words · 40 hedging words — hover to read both lists.
Each point sits at its filing date and is held flat until the next filing.